A polymorphism in the OPRM1 3′-untranslated region is associated with methadone efficacy in treating opioid dependence

A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia

(2015) Lucy Burns et al.   ADDICTION

Evidence of CNIH3 involvement in opioid dependence

(2015) E C Nelson et al.   MOLECULAR PSYCHIATRY

Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START)

(2015) Jennifer S. Potter et al.   Journal of Studies on Alcohol and Drugs

The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study

(2014) Louisa Degenhardt et al.   ADDICTION

Topiramate Treatment for Heavy Drinkers: Moderation by aGRIK1Polymorphism

(2014) Henry R. Kranzler et al.   AMERICAN JOURNAL OF PSYCHIATRY

Analysis of candidate genes for morphine preference quantitative trait locus Mop2

(2014) G.A. Doyle et al.   NEUROSCIENCE

Genome-Wide Association Study of Opioid Dependence: Multiple Associations Mapped to Calcium and Potassium Pathways

(2013) Joel Gelernter et al.   BIOLOGICAL PSYCHIATRY

An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans

(2013) Richard C Crist et al.   NEUROPSYCHOPHARMACOLOGY

Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females

(2013) T-K Clarke et al.   PHARMACOGENOMICS JOURNAL

Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis

(2012) Antonio-Javier Chamorro et al.   ADDICTION BIOLOGY

Case–control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations

(2012) R.C. Crist et al.   DRUG AND ALCOHOL DEPENDENCE

Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial

(2012) Andrew J. Saxon et al.   DRUG AND ALCOHOL DEPENDENCE

Birth and expression evolution of mammalian microRNA genes

(2012) J. Meunier et al.   GENOME RESEARCH

Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States

(2011) Howard G. Birnbaum et al.   PAIN MEDICINE

Sex differences amongst dependent heroin users: Histories, clinical characteristics and predictors of other substance dependence

(2010) Fiona L. Shand et al.   ADDICTIVE BEHAVIORS

Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment

(2010) Vadim Yuferov et al.   Annals of the New York Academy of Sciences

Yin Yang 1 Phosphorylation Contributes to the Differential Effects of μ-Opioid Receptor Agonists on MicroRNA-190 Expression

(2010) Hui Zheng et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

β-Arrestin2 influences the response to methadone in opioid-dependent patients

(2010) B Oneda et al.   PHARMACOGENOMICS JOURNAL

Fine-tuning the brain: MicroRNAs

(2009) Erno Vreugdenhil et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Small but influential: the role of microRNAs on gene regulatory network and 3′UTR evolution

(2009) Rui Zhang et al.   Journal of Genetics and Genomics

An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence

(2008) Raymond F. Anton et al.   ARCHIVES OF GENERAL PSYCHIATRY

RNA–protein interactions and control of mRNA stability in neurons

(2007) Federico Bolognani et al.   JOURNAL OF NEUROSCIENCE RESEARCH